Scott H. Soderling, Ph.D.: Dr. Soderling received his Ph.D. in Pharmacology at the Univ. of Washington. As an HHMI postdoctoral fellow he uncovered a new neuronal cytoskeletal signaling complex implicated in intellectual disability that facilitates synaptogenesis. He was recruited to Duke University in 2005. Dr. Soderling serves as the Chair of Cell Biology and is the Scientific Director of the Duke Mouse Transgenic Facility.
Akiyoshi Uezu, M.D., Ph.D.: Dr. Uezu received his MD/Ph.D at Kumamoto University in Japan. Since joining the lab Dr. Uezu has pioneered the development of new proteomic approaches. He has used these novel methods to identify the molecular complexes that mediate synaptic inhibition in vivo.
Jamie Courtland, B.S. Biology (Haverford College): Jamie joined our lab in 2017 as part of the Medical Scientist Training Program of Duke Medical School. Jamie is interested in merging the biological mechanisms of neurodevelopmental disorders with her medical school training. She is studying the molecular mechanisms that regulate inhibitory neuronal populations that are highly implicated in psychiatric disorders.
Yudong Gao, Ph.D.: Dr. Gao obtained his Ph.D. from the University of Tennessee Memphis and joined the lab in 2016. Dr. Gao studies the molecular mechanisms of plasticity at inhibitory synapses.
Erin Hisey, Ph.D. Neuroscience (Duke University). Dr. Hisey joined our lab in 2018. She is working to understand the underlying synaptic to neural circuit basis for cognitive deficits in several mouse models of intellectual disability.
Tyler Bradshaw, B.S. Cell & Molecular Biology (University of Washington): Tyler previously worked in our laboratory as a research technician before joining on as a graduate student through the Duke Neurobiology program. As a technician, Tyler worked with Aki to develop a proteomic approach to identity inhibitory synaptic proteins. As a graduate student he following up on this study by developing high-throughput functional screens to quantify mechanisms of inhibition relevant to epilepsy.
Shataakshi Dube, B.S. Biology (Butler University): Shataakshi joined the lab in 2016 through the Neurobiology program. She recently attended the Cold Spring Harbor course on Ion Channels and Synaptic Transmission and is now studying how actin remodeling modulates presynaptic properties.
Julie Kent, B.S. Zoology (Michigan State University): Julie is our lab manager and keeps us happy and organized with a well-running laboratory. Using her expertise in animal husbandry and transgenic mouse technologies, she is also spearheading novel ideas and experiments for new transgenics to uncover the molecular landscape of neuronal cell interactions.
Tetsuya Takano, Ph.D.: Tetsuya received his PhD from Tokyo Metropolitan University. Dr. Takano is developing a novel in vivo BioID proteomic approach to investigate novel mechanisms of synaptic modulation in mice.
Eda Erata, B.S. Molecular Biology & Genetics (Sabanci University, Istanbul, Turkey): Eda joined our lab through the Duke PhD program in Cell and Molecular Biology. She is using CRISPR-genome editing and in vivo BioID to tackle endogenous synaptic proteomes linked to Autism Spectrum Disorders.
Evan Brown, B.S. Chemistry (UNC-Asheville): Evan uses his expertise in molecular biology to assist the lab in generating and evaluating various novel CRISPR-based approaches for understanding how synaptic molecules function in vivo.
John Wallace, B.S. Biology and Psychology (James Madison University): John works with Tetsuya to develop and utilize innovative in vivo proteomic and genome editing approaches to reveal molecular mechanisms that drive the neuronal synaptic functions of astrocytes.